Moreover, ACE inhibitors are widely used to mitigate these adverse effects, offering therapeutic benefits in the management of T2D by improving glycemic control and protecting against T2D-induced kidney and vascular damage [58,59]. Here, ACE is linked to type 2 diabetes mellitus.